BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1849894)

  • 1. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thrombin's clotting activity by synthetic peptide segments of its inhibitors and substrates.
    Hortin GL; Benutto BM
    Biochem Biophys Res Commun; 1990 Jun; 169(2):437-42. PubMed ID: 2357214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL; Tollefsen DM; Benutto BM
    J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of the activity of thrombin.
    Duffy EJ; Angliker H; Le Bonniec BF; Stone SR
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):361-5. PubMed ID: 9020867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity.
    Liu LW; Vu TK; Esmon CT; Coughlin SR
    J Biol Chem; 1991 Sep; 266(26):16977-80. PubMed ID: 1654318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG; Erickson BW; Hermans J
    FEBS Lett; 1990 Sep; 270(1-2):85-9. PubMed ID: 2226793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bovine thrombomodulin on the specificity of bovine thrombin.
    Jakubowski HV; Kline MD; Owen WG
    J Biol Chem; 1986 Mar; 261(8):3876-82. PubMed ID: 3005304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors.
    Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT
    J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
    J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
    Myles T; Le Bonniec BF; Stone SR
    Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of BPTI interaction with human alpha- and zeta-thrombin.
    De Cristofaro R; Landolfi R
    Eur J Biochem; 1999 Feb; 260(1):97-102. PubMed ID: 10091588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for inhibiting the effects of thrombin.
    Harker LA
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S47-58; discussion S59-64. PubMed ID: 8186356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues.
    Tsiang M; Lentz SR; Dittman WA; Wen D; Scarpati EM; Sadler JE
    Biochemistry; 1990 Nov; 29(47):10602-12. PubMed ID: 2176873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation.
    Stearns DJ; Kurosawa S; Esmon CT
    J Biol Chem; 1989 Feb; 264(6):3352-6. PubMed ID: 2536746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of thrombin exosites in inhibition by heparin cofactor II.
    Rogers SJ; Pratt CW; Whinna HC; Church FC
    J Biol Chem; 1992 Feb; 267(6):3613-7. PubMed ID: 1740413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides.
    Huang RS; Sorisky A; Church WR; Simons ER; Rittenhouse SE
    J Biol Chem; 1991 Oct; 266(28):18435-8. PubMed ID: 1655750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.